APG Asset Management US’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
APG Asset Management US's PFE Position: Q4 2025 in Review
APG Asset Management US sold out of Pfizer (PFE) in Q4 2025, closing a stake of 119,114 shares — an estimated $3.24M sold.
APG Asset Management US first reported a position in PFE in Q4 2023 and held it in 8 quarters. The position peaked at $20.3M in Q4 2023. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- APG Asset Management US reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- APG Asset Management US sold 119,114 Pfizer shares in Q4 2025, an estimated $3.24M.
- APG Asset Management US first reported a position in Pfizer in Q4 2023 and held it in 8 quarters.
- APG Asset Management US's Pfizer position peaked at $20.3M in Q4 2023.
- 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.